Lornoxicam 40 mg + Paracetamol 1500 mg Bolus

A veterinary bolus combining lornoxicam and paracetamol, supplied in a blister pack of four. Intended to support pain and fever management in livestock. Use only under the guidance of a veterinarian and follow the prescribed dosage.

Lornoxicam 40 mg + Paracetamol 1500 mg Veterinary Bolus (1×4 Blister) is a combination veterinary analgesic, anti-inflammatory and antipyretic formulation containing lornoxicam and paracetamol, designed to help manage pain, inflammation and elevated body temperature in animals when prescribed for an appropriate species and condition. Lornoxicam belongs to the non-steroidal anti-inflammatory drug (NSAID) class and works by inhibiting cyclooxygenase enzymes, particularly COX-1 and COX-2, which are involved in the production of prostaglandins responsible for pain, swelling and inflammation. By reducing prostaglandin production, lornoxicam helps relieve inflammatory discomfort and improve mobility. Paracetamol acts as an analgesic and antipyretic agent, helping reduce pain and fever through its central mechanisms of action. The combination may provide complementary relief in selected conditions associated with pain, inflammation and fever, depending on the approved veterinary formulation. In veterinary practice, these types of medicines may be considered for supportive management of inflammatory and painful conditions, including musculoskeletal discomfort and fever associated with certain illnesses, but the specific indications must be confirmed for the intended animal species. The bolus dosage form is designed for oral administration and offers a convenient method of dosing when used according to veterinary instructions. The 1×4 blister pack generally indicates four boluses per pack, subject to the manufacturer's packaging convention. Possible adverse effects may include loss of appetite, digestive irritation, vomiting, diarrhoea, gastrointestinal ulceration and kidney-related complications. Paracetamol overdose may cause serious liver toxicity, while NSAIDs require particular caution in dehydrated animals and those with kidney, liver or gastrointestinal disorders. The stated strengths of Lornoxicam 40 mg and Paracetamol 1500 mg should be carefully verified against the approved product composition, target animal species and recommended dosage before marketing or administration. The product should be used only under veterinary supervision, should not be combined with other NSAIDs or paracetamol-containing medicines unless specifically advised by a veterinarian, and must be administered according to the animal's body weight and approved label instructions. Applicable meat and milk withdrawal periods must also be observed in food-producing animals.